NCT02452281 2016-01-25Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced MelanomaThe University of Texas Health Science Center, HoustonPhase 1/2 Withdrawn